首页> 外文会议>Conference on Optics in health care and biomedical optics >Heptamethine cyanine-based small molecular cancer theranostic agents
【24h】

Heptamethine cyanine-based small molecular cancer theranostic agents

机译:基于庚啶的氰基小分子癌治疗剂

获取原文

摘要

Cancer theranostic agents with a combination of cancer therapy and real-time imaging/diagnosis, provide a promising prospect for individualized and precise cancer treatment. Here, a series of structure-inherent multifunctional fluorescent small molecules, namely heptamethine cyanine dyes, were developed simultaneously for tumor-targeting, near-infrared imaging and therapy. Obtainment of cancer theranostic agents based on structure-inherent multifunctional small molecules, is a simple and straightforward way, and small molecules have advantages of easy, low-cost and large-scale synthesis, including good repeatability and quality control. Therefore, our findings may provide an alternative approach to develop multifunctional cancer theranostic agents.
机译:癌症治疗剂与癌症治疗和实时成像/诊断的组合,为个性化和精确的癌症治疗提供了一个有希望的前景。这里,一系列结构固有的多功能荧光小分子,即己酰胺氰胺染料,同时开发用于肿瘤靶向,近红外成像和治疗。基于结构固有的多官能小分子获得癌症治疗剂,是一种简单且直接的方式,小分子具有简单,低成本和大规模合成的优点,包括良好的重复性和质量控制。因此,我们的研究结果可以提供一种替代方法来开发多功能癌症治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号